Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase IIa double-blind randomized trial of Galgeun-tang in early type 2 diabetes and impaired fasting glucose
KCT0009972Phase 2Not yet recruiting
- Sponsor
- Ministry of Health & Welfare
- Start
- Feb 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ge-gen-tang in type 2 diabetes mellitus (T2DM), impaired fasting glucose (IFG), sponsored by Ministry of Health & Welfare. Planned start Feb 2024; status: not yet recruiting.
02
Drugs
ge-gen-tang
03
Conditions
type 2 diabetes mellitus (T2DM)impaired fasting glucose (IFG)
Beyond the preview
Go deeper on KCT0009972.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on KCT0009972.